Trevena Inc (FRA:6T4)
€ 3.825 0 (0%) Market Cap: 1.32 Mil Enterprise Value: 24.14 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 23/100

Q3 2021 Trevena Inc Earnings Call Transcript

Nov 15, 2021 / 01:00PM GMT
Release Date Price: €401.88 (-17.30%)
Operator

Good day, and thank you for standing by. Welcome to the Trevena Third Quarter 2021 Financial Results Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Barry Shin, Senior Vice President and Chief Financial Officer. Please go ahead.

Barry Shin
Trevena, Inc. - Senior VP & CFO

Good morning, and welcome, everyone. With me today are Carrie Bourdow, our President and CEO; Patty Drake, our newly announced Chief Commercial Officer; Bob Yoder, our Chief Business Officer and Head of Commercial Operations; and our Chief Medical Officer, Mark Demitrack. We're also joined by Dr. Paul Rider from the University of South Alabama.

Dr. Ryder will share his firsthand experience with OLINVYK, both as an investigator in our Phase III open-label safety study and in his colorectal surgery practice where OLINVYK is approved for use. At the end of the call, we'll open it up for questions.

As a reminder, OLINVYK is approved in adults for the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot